Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Controlled Study to Demonstrate the Efficacy and Safety of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation

NCT00755781 is registered in ClinicalTrials.gov with APT Pharmaceuticals, Inc. as lead sponsor.

NCT NCT00755781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00755781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Controlled Study to Demonstrate the Efficacy and Safety of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation
Lead sponsor
APT Pharmaceuticals, Inc.
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2008
Completion date
November 30, 2011
Enrollment
284 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

lung transplant